Life Sciences atai Life Sciences Increases Its Ownership Position in COMPASS Pathways AIT News Desk Nov 29, 2021 Demonstrates atai’s confidence in COMPASS’ Phase 2b data and its potential for patients with treatment-resistant depression atai Life Sciences, a…
Life Sciences ATAI Launches Introspect Digital Therapeutics, Appoints Veteran Software Engineer David Keene as CEO AIT News Desk Jun 22, 2020 Today, ATAI Life Sciences, a global biotech developing psychedelic and non-psychedelic compounds for various mental health indications, announced the…